Physiological-social score (PMEWS) vs. CURB-65 to triage pandemic influenza: a comparative validation study using community-acquired pneumonia as a proxy by Challen, Kirsty et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Health Services Research
Open Access Research article
Physiological-social score (PMEWS) vs. CURB-65 to triage 
pandemic influenza: a comparative validation study using 
community-acquired pneumonia as a proxy
Kirsty Challen*1, John Bright2, Andrew Bentley3 and Darren Walter4
Address: 1Emergency Medicine and Planning, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK, 2Respiratory 
Medicine, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK, 3Respiratory Medicine and Critical Care, University 
Hospital of South Manchester NHS Foundation Trust, Manchester, UK and 4Emergency Medicine, University Hospital of South Manchester NHS 
Foundation Trust, Manchester, UK
Email: Kirsty Challen* - kirsty.challen@smtr.nhs.uk; John Bright - jcbright@hotmail.com; Andrew Bentley - andrew.bentley@smtr.nhs.uk; 
Darren Walter - darren.walter@smtr.nhs.uk
* Corresponding author    
Abstract
Background: An influenza pandemic may increase Emergency Department attendance 7-fold. In
the absence of a validated "flu score" to assess severity and assist triage decisions from primary into
secondary care, current UK draft management recommendations have suggested the use of CURB-
65 and chest X-ray as a proxy. We developed the Pandemic Medical Early Warning Score (PMEWS)
to track and triage flu patients, taking into account physiological and social factors and without
requiring laboratory or radiology services.
Methods: Validation of the PMEWS score against an unselected group of patients presenting and
admitted to an urban UK teaching hospital with community acquired pneumonia. Comparison of
PMEWS performance against CURB-65 for three outcome measures: need for admission,
admission to high dependency or intensive care, and inpatient mortality using area under ROC
curve (AUROC) and the Hanley-McNeil method of comparison.
Results: PMEWS was a better predictor of need for admission (AUROC 0.944) and need of higher
level of care (AUROC 0.83) compared with CURB-65 (AUROCs 0.881 and 0.640 respectively) but
was not as good a predictor of subsequent inpatient mortality (AUROC 0.663).
Conclusion: Although further validation against other disease datasets as a proxy for pandemic
flu is required, we show that PMEWS is rapidly applicable for triage of large numbers of flu patients
to self-care, hospital admission or HDU/ICU care. It is scalable to reflect changing admission
thresholds that will occur during a pandemic.
Background
As part of planning for a potential H5N1 influenza pan-
demic, using United Kingdom Department of Health and
Health Protection Agency projections[1], we have been
forced to acknowledge that our urban Emergency Depart-
ment, which normally sees approximately 250 patients
per day, will potentially see an additional 1500 attenders
per day with influenza-like illness and associated anxiety
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at a pandemic peak. The potential magnitude of the "wor-
ried well" attendance is supported by the experience of the
Dutch Municipal Health Service during the H7N7 avian
outbreak in 2003 where of 453 patients presenting to a
screening centre only 109 were serologically positive for
influenza[2].
In the absence of diagnostic criteria, and a validated influ-
enza "severity scoring system", current draft plans use
instruments designed for the assessment of pneumonia
severity as a proxy tool. Examples include the British Tho-
racic Society's CURB-65, the American Thoracic Society
guidelines[3] and the Pneumonia Severity Index[4]. These
have been validated as predictors of mortality in a popu-
lation with community acquired pneumonia[5] and
include either radiological or laboratory investigations.
This renders them cumbersome and mandates hospital-
based assessment for a decision on the need for admission
or discharge.
We designed a simple and rapidly applicable purely clini-
cal scoring system for use in primary and secondary care
and at other points of contact with health providers in the
community. This tool is not intended to be diagnostic, as
during a pandemic all patients with influenza-like illness
will be assumed to have pandemic influenza[6]. Our aim
was to create a screening tool for adults to identify the
need for hospital admission and importantly to reassure
and discharge those who do not require hospitalisation at
the point of assessment. We suggest the ideal score should
reflect acute physiological derangement but also consider
and accommodate age, chronic disease co-morbidities
and other social factors. It will be necessary for such a
scoring system to be used serially to triage and determine
the need for admission and for higher levels of care[7] and
even possibly predict mortality. When applied across a
health economy, it should provide consistency and reas-
surance to those patients who seek alternative opinions
from a number of sources.
We therefore modified our hospital Medical Early Warn-
ing Score[8] to include transcutaneous oxygen saturation
and added supplementary scoring features of co-morbid-
ity and social factors to influence the threshold for making
admission and discharge decisions (Pandemic Medical
Early Warning Score; PMEWS). Our score incorporates an
extra point for age ≥ 65 years and another for any of a)
social isolation (defined as living alone or having no fixed
abode), b) chronic disease (respiratory, cardiac, renal, dia-
betes mellitus or immunosuppression of any cause) or c)
performance status of limited activity or worse (modified
Karnofsky >2[9]). Fig 1 summarises the full score with
symptomatology to be defined by World Health Organi-
sation as disease evolution takes place.
We describe the first validation of the PMEWS scoring sys-
tem in an unselected population of patients with commu-
nity acquired pneumonia (as a proxy for pandemic
influenza) presenting and admitted to our urban teaching
hospital from February to December 2005. We compared
it with the current UK standard for community-acquired
pneumonia, the CURB-65 score, which has also been rec-
ommended as an instrument for triage in the event of an
influenza pandemic[1].
Methods
The University Hospital of South Manchester NHS Foun-
dation Trust is an 895-bed urban teaching hospital pro-
viding secondary care services to a population of 500,000
and tertiary care in burns and plastic surgery, cardiology,
cardiothoracic surgery, maxillofacial surgery, vascular sur-
gery and respiratory medicine. The Emergency Depart-
ment sees 78000 new attendances per year both by
Primary Care referral and from self-attendance. An Early
Warning Score was, at the time of data collection, used by
the nursing staff to identify higher-risk patients but this
and CURB-65 were used for admission decision-making
only at the doctors' discretion.
The study population consisted of a) all adult (> 15 years
old) patients presenting to the Emergency Department
who were deemed by the Emergency Physician to have
pneumonia and b) all adult patients admitted to the hos-
pital whose discharge diagnostic code included ICD-10
J18 (pneumonia) and where non-aspiration pneumonia
was the working diagnosis at first consultant contact fol-
lowing admission. Patients were excluded if, on review of
the case notes, insufficient data was present to calculate a
PMEWS or CURB-65 score, or if it was apparent from the
case notes that the pneumonia was hospital-acquired, or
that the reason for admission was another diagnosis.
Immunocompromised patients were specifically not
excluded as immune status is often unknown at presenta-
tion and previous research has demonstrated mixed
results in terms of the effect of immunosuppression on
outcome[10,11]. South Manchester Local Research Ethics
Committee waived the need for formal ethical approval as
no additional direct patient contact was involved.
The study population was a retrospectively identified
cohort for the period February – December 2005 using the
Emergency Department local coding system and the hos-
pital Patient Administration System (IBA inc). Contempo-
raneous data was collected to calculate the PMEWS and
CURB-65 scores using the Emergency Department nursing
and medical records and the admitting physician clerking.
Where data varied, the earliest recorded information was
used. If data on one or two variables was missing this was
assumed to be normal. If data on three or more was miss-
ing the patient was excluded.BMC Health Services Research 2007, 7:33 http://www.biomedcentral.com/1472-6963/7/33
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The reference standards, to reflect the clinically significant
decision points, were a) admission to hospital on the day
of examination, b) admission to the intensive care (ITU)
or high dependency (HDU) units or the use of non-inva-
sive ventilation at any time during the admission, c) mor-
tality during in-patient stay.
Data was analysed using SPSS 11.5 (SPSS inc®) to calculate
ROC curves. The z-statistic for comparison between ROC
curves was calculated using the method described by
Hanley and McNeil[12], with a z-value of >1.96 consid-
ered significant at the 95% confidence level.
Results
Patients identified from February – December 2005 are
shown in Fig 2. 31 patients referred directly from general
practice to inpatient teams for admission were not treated
by the Emergency Department and have therefore not
been included in the analysis of admission/discharge
decisions. 37 ED patients had insufficient data in the case-
notes to complete either CURB-65 or MEWS scores and
were therefore pragmatically excluded. Baseline demo-
graphics are shown in table 1. 194 patients were admitted
of which 8 sets of notes were unavailable. 42 received
HDU or ITU care (23 intubated and ventilated, 12 non-
invasively ventilated) and a further 42 were deemed inap-
propriate for HDU/ITU care due to pre-existing comorbid-
ities or performance status or to patient preference. 42
patients died.
Table 2 shows the three outcome measures stratified by
CURB-65 and PMEWS scores. Table 3 shows predictive
values for various cut-off points for each of the scores. Figs
3, 4, 5 show ROC curves with AUROC and 95% confi-
PMEWS algorithm Figure 1
PMEWS algorithm.
Date: _____________ P-MEWS
Time: _____________ Admission Algorithm
v0.3 29/03/06 J Bright, K Challen, A Bentley, D Walter Copyright
Patient ID label or:
Name: ________________________
Age/dob: ________________________
Address: ________________________
________________________
________________________
GP: ________________________
Practice: ________________________
Pandemic Flu Symptoms:
As set by WHO e.g. (tick) Fever> 38
oC Sore Throat
Cough Myalgia
SOB Watery Diarrhoea
PLUS
Physiological Data (MEWS)
Ring 1 value for each factor
Total P-MeWS =
Boxes completed by local health economy to determine admission criteria
S C O R E 3 2 1 01 23
Resp Rate ≤ 8 9-18 19-25 26-29 ≥ 30
O2 Sats <89 90-93 94-96 >96
Heart Rate ≤ 40 41-50 51-100 101-110 111-129 ≥ 130
Systolic BP ≤ 70 71 - 90 91 - 100 >100
Temp ≤35.0 35.1-36 36.1-37.9 38-38.9 ≥ 39
Neuro Alert
Confused
Agitated
Voice
Pain
Uncon
Patient Data
Score 1 for each factor
Age >65 …………………
Social Isolation …O R……
Lives alone/No fixed abode
Chronic Disease …O R…. .
Respiratory, cardiac, renal, immunosuppressed, DM
Performance Status >2 …
Normal activity without restriction 1
Strenuous activity limited, can do light 2
Limited activity but capable of self care 3
Limited activity, limited self care 4
Confined to bed/chair, no self care 5
Name of assessor: _____________________
Grade: _____________________
Signature: _____________________
Admission advised if:
- Mews≥ and Patient≥
or
- Mews≥BMC Health Services Research 2007, 7:33 http://www.biomedcentral.com/1472-6963/7/33
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dence intervals for each of the outcome measures. Once
admitted to hospital, the social factor becomes irrelevant
and is not included as a discriminator for higher level care
or mortality. Calculations for HDU/ITU care exclude
those patients for whom it was deemed inappropriate.
The z-statistic as described by Hanley and McNeil is 3.09
for admission decision, 3.76 for admission to HDU/ITU
care, and 2.48 for mortality.
Discussion
The PMEWS score performs well for discerning those
patients in need of admission (area under ROC curve
0.944) and triages effectively those in need of higher levels
of care before irreversible organ dysfunction is established
(area under ROC curve 0.83), whereas CURB-65 achieves
comparable areas under the ROC curve of only 0.81 and
0.64 respectively. PMEWS is particularly strong in the
mid-range of values where we hypothesise those patients
who are most likely to benefit from intensive treatment
lie. It provides quick and simple but robust information
and could be applied consistently at the Emergency
Department, in the General Practice surgery, at proposed
Community "Flu Centres" and even by District Nurses
and the Ambulance Service paramedics and Emergency
Care Practitioners seeing patients in their own homes.
CURB-65, in comparison, requires laboratory investiga-
tion and, as has been noted elsewhere, is not particularly
effective at identifying patients requiring higher levels of
care[13]. If CRB-65 is employed by removing the need for
laboratory investigations as has been suggested in the BTS
guidelines, this score is further weakened in its ability to
identify patients requiring higher levels of care. It has also
been noted that CURB-65 may be misleadingly low in fit
young adults with certain atypical pneumonias[14].
CURB-65 remains a strong tool for the prognostication of
mortality, the task for which it was originally designed.
The PMEWS score was designed from a generic early warn-
ing score as an isolated rapid "snapshot" tool which relies
on physiological derangement at the time of assessment
for triage to appropriate levels of care. A single physiolog-
ical assessment at admission cannot be expected to per-
form well as a mortality predictor over the course of an
entire hospital admission. We note that our mortality rate
(at 22.5%) is higher than previous reports of community-
acquired pneumonia but suggest that this is due to our
pragmatic inclusive strategy; Fine, for example, excluded
patients from nursing homes[11]. The mean age of our
patients, at 70.9 years is notably higher than that studied
by Kamath et al, which was 58.8 years[15], and 70% of
our patients were aged 65 or over, compared with 58% of
Lim et al's group[16].
National predictions on the incidence of a pandemic
influenza[1], together with the inevitable complication of
the "worried well" seeking reassurance, suggest an
increase in Emergency Department attendance of 700%,
mandating a new approach to triage and assessment of
patients with influenza related illness. While clinical intu-
ition may be the mainstay of assessment, an objective and
effective decision tool applied consistently across a health
economy should instil confidence both in the decision
makers and the patient population and may reduce the
level of "second opinion" seeking. There will need to be
empowerment of a wide variety of healthcare profession-
als to make decisions about management and destination
to manage the patient surge and we believe that an objec-
tive scoring system based on simple physiology is appro-
priate. It is not feasible, at least within our institution, that
our pathology or radiology services will be able to per-
form in the region of 900 extra serum urea analyses or
chest X-rays per day. Although concerns have recently
been expressed about the practical applicability of an early
warning score during disease outbreaks[17], the concept
has a precedent in Critical Care Outreach for determining
need for higher levels of care amongst a general ward pop-
ulation. Early Warning Scores (EWS) are already in wide-
spread use in hospitals throughout the UK. They are tools
Table 1: Demographic characteristics
Decision to admit analysis (n = 242)
Age ≥ 65 127 (52.5%)
Socially isolated 75 (31.0%)
Relevant comorbidities 102 (42.1%)
Performance status ≥ 3 82 (33.9%)
Level II/III care and mortality analysis (n = 186)
Age ≥ 65 131 (70.4%)
Relevant comorbidities 60 (32.3%)
Performance status ≥ 3 93 (50%)BMC Health Services Research 2007, 7:33 http://www.biomedcentral.com/1472-6963/7/33
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familiar to many health care providers whereas CURB-65
may have a more limited appeal and familiarity[18].
It is likely that in a pandemic thresholds for hospital
admission will be higher than is current practice. While it
is impractical prospectively to validate a pandemic score
in the absence of a pandemic, we believe that the perform-
ance of PMEWS in identifying patients currently admitted
to higher-intensity care demonstrates its scalability for
greater numbers. Whatever the nature of the illness, deci-
sions relating to the need for hospital admission relate to
the physiological state and the potential for further deteri-
oration where intervention may limit or prevent this. In
the face of overwhelming demand, the threshold for ther-
apeutic intervention and admission could be altered by
raising the decision score required within PMEWS, as
demonstrated in table 2. This "degradation of care with
scale" as demand outstrips supply is a recognised part of
Cohort diagram Figure 2
Cohort diagram.
Total patients 
identified via 
ED n=343 
Excluded: not 
pneumonia 
n=65 
Eligible patients 
n=278 
Excluded: 
inadequate data 
recorded in ED 
casenotes n=37
Analysis 
completed for 
admission 
criteria n=241 
Not admitted 
n=76 
Analysis 
completed for 
mortality 
n=186 
Missing 
inpatient notes 
n=8 
Admitted 
directly from 
GP n=31 
Patients 
deemed not 
suitable for 
ICU n=42 
Analysis 
completed for 
level II/III care 
n=144 BMC Health Services Research 2007, 7:33 http://www.biomedcentral.com/1472-6963/7/33
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the need to do the most for the largest number of patients
and would not be achievable within the relatively limited
confines of CURB-65.
No disease-related scoring system can confidently be
stated at present to be appropriate for application to pan-
demic influenza since the actual nature of the disease is
unknown. Although we present here validation against a
relatively small population with community-acquired
pneumonia, further validation using wider patient sets
(including SARS, sepsis and unselected ED presentations)
is ongoing. Our patient physiology and social circum-
stances based score could be used as an admission deci-
sion tool, whatever the nature of the final presentation of
the next pandemic of influenza. As the numbers rise,
knowledge of the course of the disease becomes more
established and capacity of hospitals declines, then there
is capacity for scaling the referral to hospital/admission
criteria by adjusting the score threshold for referral. We
believe that, when adopted across a health economy, the
adjustable threshold of PMEWS will greatly enhance the
decision value of the system, compared with the relative
inflexibility of a scoring system such as CURB-65.
Conclusion
Although no scoring system can be fully validated for an
influenza pandemic given that the pattern of the disease is
currently unknown, we have demonstrated, using com-
munity-acquired pneumonia as a proxy, that a non-dis-
ease-specific physiological-social score performs as
effectively to triage patients to appropriate levels of care as
a disease-specific score.
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Table 2: Outcome measures by CURB-65 and PMEWS score
Outcome 1: Admission n = 241 Outcome 2: ICU (level 3) or HDU (level 2) care n = 144 Outcome 3: Mortality n = 186
Admitted Not admitted Level 2/3 care Level 0/1 care Death Survival
CURB-65 0 16 53 0 12 0 15
14 0 1 9 5 3 5 2 4 4
2 42 5 12 30 9 39
3 39 0 15 19 13 34
42 3 0 2 1 2 1 5 1 1
5 4 0 023 1
P M E W S 0 1 2 0 020 2
1 1 2 2 070 7
2 8 1 3 190 1 1
31 2 1 2 0 1 8 3 1 9
41 6 6 2 1 3 5 1 2
52 0 3 1 2 1 5 2 6
61 5 1 4 1 1 5 1 5
72 4 0 4 1 4 5 1 7
8 1 4 0 473 1 1
9 1 6 0 837 9
10 13 0 6 2 3 8
1 1 9 0 113 2
1 2 5 0 112 2
1 3 3 0 010 1
1 4 2 0 101 1
1 5 1 0 000 0
1 7 1 0 100 1
2 4 1 0 000 0
N
R
20
NR: not recordedBMC Health Services Research 2007, 7:33 http://www.biomedcentral.com/1472-6963/7/33
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ROC curve for admission to level 2 or 3 care Figure 4
ROC curve for admission to level 2 or 3 care.
Table 3: Predictive value of scores
Score Sensitivity Specificity PPV NPV
Outcome: admission CURB-65 ≥ 2 6 59 39 55 6
CURB-65 ≥ 34 0 1 0 0 1 0 0 4 4
P M E W S > 1 9 85 58 29 5
P M E W S > 2 9 37 18 78 4
P M E W S > 3 8 68 79 37 5
P M E W S > 4 7 69 49 66 5
P M E W S > 5 6 49 89 95 6
PMEWS>7 40 100 100 44
PMEWS>9 21 100 100 37
PMEWS>11 8 100 100 34
Outcome: HDU/ITU 
admission
CURB-65 ≥ 3 5 07 03 48 1
P M E W S > 3 9 73 23 09 7
P M E W S > 4 9 14 53 49 4
P M E W S > 5 8 86 44 39 5
P M E W S > 6 7 67 44 79 1
P M E W S > 7 6 48 65 98 9
P M E W S > 9 2 99 56 78 1
P M E W S > 1 1 8 9 86 07 8
PPV: positive predictive value
NPV: negative predictive value
ROC curve for admission decision Figure 3
ROC curve for admission decision.BMC Health Services Research 2007, 7:33 http://www.biomedcentral.com/1472-6963/7/33
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Appendix 1
CURB-65 score
One point for each of:
Confusion
Urea >7 mmol/l
Respiratory rate >= 30/min
low systolic (<90 mmHg) or diastolic (<= 60 mmHg)
Blood pressure
age >= 65 years
British Thoracic Society. Guidelines for the management
of community acquired pneumonia in adults – 2004
update. London: British Thoracic Society, 2004.
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